Related Experiment Videos
Co-antibodies in human leptospirosis
Bollettino Dell'Istituto Sieroterapico Milanese
|January 1, 1976
Summary
Human leptospirosis can trigger the formation of co-antibodies against various leptospira serotypes. These antibodies may be linked to changes in the bacteria
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Leptospirosis is a zoonotic disease caused by pathogenic Leptospira bacteria.
- Understanding the immune response, including co-antibody formation, is crucial for diagnosis and treatment.
- Leptospiral antigens can be serotype-specific, genus-specific, or intertype.
Purpose of the Study:
- To review investigations on co-antibodies in human leptospirosis.
- To analyze the associations of co-antibodies with different leptospiral serotypes.
- To explore potential biological interpretations for co-antibody formation.
Main Methods:
- Review of existing literature on leptospiral co-antibodies and antigens.
- Analysis of co-antibody associations using the Microscopic Agglutination (MAL) test and Complement Fixation (CF) test.
- Testing with 20 pathogenic and water serotypes of Leptospira.
Main Results:
- Human leptospirosis induces high-titer co-antibodies, both agglutinating and complement-fixing.
- These co-antibodies are often associated with serotype antigens not belonging to the infecting strain.
- Genus-specific and intertype antigens, located deep within leptospiral cells, are not identified by the MAL test.
Conclusions:
- The formation of co-antibodies in leptospirosis suggests a complex immune response.
- A hypothesis proposes that antigenic changes in Leptospira strains (in vivo or in vitro) may drive co-antibody production.
- Further research is needed to fully elucidate the mechanisms and implications of co-antibody formation in leptospirosis.